*001421385
*00520200803141309.0
*007ta
*008191003s2019    no a   e m    00  0 eng
*00901767nam a2200337 c 4500
*019  $bl
*020  $a9788283774979$qheftet
*035  $a(EXLNZ-47BIBSYS_NETWORK)999920918484202201
*035  $a(NO-LaBS)14720886(bibid)
*040  $aNO-OsNB$bnob$erda
*060 4$aWI 420
*1001 $aBuer, Lydia Celine Tansem$d1984-$0(NO-TrBIB)11083690$4aut$_70908200
*24510$aNew biological therapies and treatment strategies in inflammatory bowel disease :$bstudies from real world clinical practice$cLydia Celine Tansem Buer
*264 1$a[Oslo]$bInstitute of Clinical Medicine, Faculty of Medicine, University of Oslo$c2019
*300  $a1 bind (varierende paginering)$billustrasjoner$c24 cm
*336  $atekst$0http://rdaregistry.info/termList/RDAContentType/1020$2rdaco
*337  $auformidlet$0http://rdaregistry.info/termList/RDAMediaType/1007$2rdamt
*338  $abind$0http://rdaregistry.info/termList/RDACarrierType/1049$2rdact
*4901 $aSeries of dissertations submitted to the Faculty of Medicine, University of Oslo
*500  $aDelvis opptrykk av artikler
*502  $aAvhandling (ph.d.) - Universitetet i Oslo, 2019
*650 2$aAntibodies, Monoclonal, Humanized$0(DNLM)D061067$_70908300
*650 2$aBiosimilar Pharmaceuticals$xtherapeutic use$0(DNLM)D059451Q000627$_70908400
*650 2$aInflammatory Bowel Diseases$xdrug therapy$0(DNLM)D015212Q000188$_70908500
*650 2$aInfliximab$xtherapeutic use$0(DNLM)D000069285Q000627$_70908600
*7102 $aUniversitetet i Oslo$bDet medisinske fakultet$0(NO-TrBIB)90302138$4pbl$_10213300
*7102 $aUniversitetet i Oslo$bInstitutt for klinisk medisin$0(NO-TrBIB)15000758$4dgg$_10213400
*830 0$aSeries of dissertations submitted to the Faculty of Medicine, University of Oslo$x1502-9921$w990122483394702201$_204428600
*913  $aNorbok$bNB
*917  $ad
*999  $aoai:nb.bibsys.no:999920014797502202$b2021-11-14T20:19:36Z$z999920014797502202
^